Symbol Name ID |
Tra2b
transformer 2 beta MGI:106016 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Tra2bGt(P142D08)Wrst/Tra2b+ involves: 129S2/SvPas * C57BL/6J |
normal growth/size/body region phenotype | J:176730 |
normal homeostasis/metabolism phenotype | J:176730 | |
increased circulating triglyceride level | J:176730 | |
increased circulating VLDL triglyceride level | J:176730 | |
normal mortality/aging | J:176730 | |
Tra2bGt(P142D08)Wrst/Tra2bGt(P142D08)Wrst involves: 129S2/SvPas * C57BL/6J |
embryonic lethality, complete penetrance | J:176730 |
Tra2btm1.1Bwir/Tra2btm1.1Bwir involves: 129S4/SvJae * C57BL/6 * C57BL/6N * SJL |
no abnormal phenotype detected | J:159448 |
Tra2btm1.2Bwir/Tra2btm1.2Bwir involves: 129S4/SvJae * C57BL/6 * C57BL/6N |
abnormal allantois morphology | J:159448 |
abnormal vasculogenesis | J:159448 | |
decreased embryo size | J:159448 | |
embryonic lethality during organogenesis, incomplete penetrance | J:159448 | |
Tra2btm1Bwir/Tra2btm1Bwir involves: 129S4/SvJae * C57BL/6 * C57BL/6N |
prenatal lethality, complete penetrance | J:159448 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|